Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease

BACKGROUND: The inflammatory biomarker YKL‐40 has previously been studied as a potential risk marker in cardiovascular disease. We aimed to assess the prognostic reclassification potential of serum YKL‐40 in patients with stable coronary artery disease. METHODS AND RESULTS: The main study population...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroder, Jakob, Jakobsen, Janus Christian, Winkel, Per, Hilden, Jørgen, Jensen, Gorm Boje, Sajadieh, Ahmad, Larsson, Anders, Ärnlöv, Johan, Harutyunyan, Marina, Johansen, Julia S., Kjøller, Erik, Gluud, Christian, Kastrup, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335588/
https://www.ncbi.nlm.nih.gov/pubmed/32114892
http://dx.doi.org/10.1161/JAHA.119.014634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335588/
https://www.ncbi.nlm.nih.gov/pubmed/32114892
http://dx.doi.org/10.1161/JAHA.119.014634

Ejemplares similares